Photopheresis
 | This article needs additional citations for verification. (March 2014) |
| Photopheresis | |
|---|---|
| ICD-10-PCS | 6A650ZZ[note 1] |
| ICD-9 | 99.88 |
| MeSH | D017893 |
In
cytotoxic
effects on T-cell formation. The mechanism of such “antitumor” action has not been elucidated.
A 1987
U.S. Food and Drug Administration (FDA) therapy for cutaneous T-cell lymphoma. Evidence suggests that this treatment might help treat graft-versus-host disease, though this evidence is largely observational; controlled trials are needed to support this use.[4][5] Photopheresis has also been successful in treating epidermolysis bullosa acquisita when all other treatments have been ineffective.[6]
Minimal observed
autoimmune diseases, nephrogenic systemic fibrosis and ulcerative colitis
.
See also
Notes
- ^ ICD10 Procedure code: this was assigned based on cross-walking from the ICD9 code at ICD10DAta.com
References
Further reading
- Maceira Rozas MC. Fotoaféresis para pacientes con enfermedad de injerto contra huésped resistente a esteroides. Santiago de Compostela: Axencia de Avaliación de Tecnoloxías Sanitarias de Galicia, avalia-t; 2014. Available from: http://www.sergas.es/docs/Avalia-t/electroporacion/CT201402Fotoafereis_Def.pdf
External links
- American Society for Apheresis
- Extracorporeal photopheresis entry in the public domain NCI Dictionary of Cancer Terms
- Extracorporeal photopheresis definition at eMedicine.com